Reuters logo
BRIEF-VBI reports positive outcome from phase III pre-ind discussions with the FDA for hepatitis B vaccine
June 19, 2017 / 12:39 PM / 3 months ago

BRIEF-VBI reports positive outcome from phase III pre-ind discussions with the FDA for hepatitis B vaccine

June 19 (Reuters) - Vbi Vaccines Inc

* Vbi vaccines reports positive outcome from phase iii pre-ind discussions with the fda for hepatitis b vaccine, sci-b-vac(tm)

* Vbi vaccines - vbi is now in process of preparing a phase iii ind for u.s., and ctas for europe and canada, with submission planned in h2 2017

* Vbi vaccines inc - vbi plans to submit ind in second half of 2017, together with clinical trial applications (“ctas”) for europe and canada Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below